Cefamandole

Chemical formula: C₁₈H₁₈N₆O₅S₂  Molecular mass: 462.503 g/mol  PubChem compound: 456255

Therapeutic indications

Cefamandole is indicated for:

Indication

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
at least one of
Streptococcus pneumoniae
Haemophilus influenzae
Klebsiella pneumoniae
Staphylococcus aureus
Proteus mirabilis
Staphylococcus haemolyticus
and additionally Respiratory tract infection

Pneumonia due to Klebsiella pneumoniae
Pneumonia due to staphylococcus
Pneumonia due to streptococcus, group B
Pneumonia due to other streptococci
Pneumonia due to Escherichia coli
at least one of
Escherichia coli
Proteus mirabilis
Enterobacter
Klebsiella
Streptococcus, group D
and additionally Urinary tract infectious disease

Acute peritonitis and additionally at least one of
Escherichia coli
Enterobacter

Sepsis and additionally at least one of
Escherichia coli
Staphylococcus aureus
Streptococcus pneumoniae
Beta-hemolytic Streptococcus, group A
Haemophilus influenzae
Klebsiella

Infection of skin and additionally at least one of
Staphylococcus aureus
Beta-hemolytic Streptococcus, group A
Haemophilus influenzae
Escherichia coli
Enterobacter
Proteus mirabilis

Musculoskeletal infective disorder and additionally Staphylococcus aureus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Indication

Population group: only children (1 year - 12 years old)

at least one of
at least one of
Streptococcus pneumoniae
Haemophilus influenzae
Klebsiella pneumoniae
Staphylococcus aureus
Proteus mirabilis
Staphylococcus haemolyticus
and additionally Respiratory tract infection

Pneumonia due to Klebsiella pneumoniae
Pneumonia due to staphylococcus
Pneumonia due to streptococcus, group B
Pneumonia due to other streptococci
Pneumonia due to Escherichia coli
at least one of
Escherichia coli
Proteus mirabilis
Enterobacter
Klebsiella
Streptococcus, group D
and additionally Urinary tract infectious disease

Acute peritonitis and additionally at least one of
Escherichia coli
Enterobacter

Sepsis and additionally at least one of
Escherichia coli
Staphylococcus aureus
Streptococcus pneumoniae
Beta-hemolytic Streptococcus, group A
Haemophilus influenzae
Klebsiella

Infection of skin and additionally at least one of
Staphylococcus aureus
Beta-hemolytic Streptococcus, group A
Haemophilus influenzae
Escherichia coli
Enterobacter
Proteus mirabilis

Musculoskeletal infective disorder and additionally Staphylococcus aureus

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈